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IDEAS overview  
• IDEAS is an evaluation funded by the Bill & Melinda Gates 
Foundation to the London School of Hygiene & Tropical Medicine 
between 2010 & 2015  
• Aim to improve evidence for maternal & newborn health programmes 
in northeast Nigeria, Uttar Pradesh in India and Ethiopia  
Estimated 6% of the world’s 
population, 10% of global births 
and 16% of global maternal & 
newborn deaths  
IDEAS Objectives  
1. To build capacity for measurement, learning & evaluation 
2. To measure efforts to enhance interactions between families & 
frontline workers and increase the coverage of critical interventions 
3. To explore scale-up of maternal and newborn health 
innovations  
4. To investigate the impact on survival of maternal and newborn 
health innovations implemented at scale 
5. To promote best practice for policy 
 
Why study scale-up?  
• Gates foundation’s Maternal & Newborn Child Health Strategy 2009: 
substantial investments in developing & testing maternal & newborn 
health ‘innovations’ to accelerate progress towards MDGs 4 & 5  
• Grantees funded to deliver innovative health programmes in pilot 
districts  
• Acknowledged need to catalyse innovation ‘scale-up’ beyond pilot 
districts to meet needs of whole populations 
• IDEAS role: using qualitative methods to better understand how to 
catalyse scale-up: 
– Which factors enable & inhibit scale-up?  
– How to effectively catalyse scale-up of externally funded innovations? 
– How can evidence contribute to catalysing scale-up?  
 
Innovations: methods introduced by externally funded grantees 
to enhance interactions between frontline workers & household 
members 
– Strengthening capacity & motivation of frontline health workers – 
training, job aids, supervision, mobile phone technologies  
–  Awareness and behavioural change  
–  Community mobilisation  
    
Scale-up: increasing the geographical reach of a health 
programme to benefit a greater number of people beyond grantee 
pilot districts 
 
 
 
 
Definitions  
Routes to scale-up 
Grantee 
innovations 
pilot 
districts   
Community 
uptake at scale  
Government 
 
Donors 
  
Private sector  
 
Deliver 
innovations 
at scale  
Organic diffusion of innovations  
Intermediaries 
  
Active dissemination of innovations   
Qualitative study methods  
•  Annual data collection: 2012, 2013 & 2014  
•  50 semi-structured key informant interviews per geography per 
year 
• Stakeholder constituencies: government, development 
agencies, civil society, Foundation grantees, programme 
officers, academics/researchers, professional medical 
associations   
• Comparative thematic analysis of the data across the three 
geographies  
 
 
 
 
 
Key findings from northeast 
Nigeria & Uttar Pradesh   
How can externally funded grantees effectively use evidence to 
inform decisions on scaling innovations?   
 
1. Multiple types of evidence  
2. Trustworthiness of evidence  
3. Effectively communicating evidence  
4. Supporting evidence-based decision making  
5. Ongoing problems with evidence into action 
 
 
 
 
 
1 Multiple forms of evidence 
 
Generating multiple types of evidence is more powerful than single types 
of evidence:   
 
• Quantitative data demonstrating impacts: ‘You must be able to show 
that the package you are trying to sell to them has actually worked - the 
improvement in the lives of women & children...’  
 
• Estimated costs of taking innovations to scale: ‘When it’s actually 
required to take it to scale, government first asks what is the cost...’  
 
• Process data to inform implementation at scale: ‘...you actually need to 
know all the good & bad experiences from the implementation process’  
 
• Demonstrating projects, site visits, emotional buy-in: ‘I can remember 
the permanent secretary [crying] because they had never seen it... I saw 
his reaction & you know, the memo sailed through easily’  
 
 
2 Trustworthiness of evidence 
 
Evidence must be perceived as trustworthy – credible, robust, valid:  
 
• Evaluation independently conducted: ‘In retrospect [the project] should 
have been evaluated completely independently of [the grantee] 
interfering...’ 
 
• Not biased by stakeholder interests: ‘People just want to know whether it 
succeeded or not... If it succeeded people just don’t want to talk about it – 
they just want to celebrate...’  
 
• Credibility of the messenger: ‘... having people who are actually experts. 
Instead it was actually more of a public relations meeting’  
 
• Fostering decision makers’ trust: ‘Starting from the very planning phase 
itself, regular updating is the key. Take their inputs and slowly they get 
convinced when they get to see the progress of the program. They develop 
trust on the project’  
 
 
 
 
 
3 Communicating evidence 
 
Effective communication of evidence is vital:  
 
Audience  
• Targeting the right audience: ‘The dissemination meeting was not well 
attended by people who would be able to take this forward... not by very high 
level people...’ 
 
Format  
• Formats appropriate to the audience: ‘...if I’m presenting to commissioners 
for health I better have my statistics, my pie charts, my bar diagrams...’  
• Adherence to traditional authority, etiquette: ‘[if you want to present to the 
Emir of Kano] you’d better wear a white robe & a red cap...’  
 
Timing  
• Timing communication around decision making cycles: ‘...the time period 
of interface with the policymaker is very short’ 
• Continual advocacy: ‘...from the beginning to the end you’ve got to have 
[government] involved...’   
 
4 Supporting evidence-based decision making 
 
Supporting decision makers to use evidence may be necessary:  
 
• Building decision makers’ capacity to understand & value evidence:  
‘We have to understand how a policymaker is trained to appreciate the data – 
he cannot appreciate the data the way a researcher does...’  
• Invoking champions: ‘...it beholds you as an external person to do a little 
stakeholder mapping – know who your allies are – preach to them, empower 
them, make them understand, see the evidence, share your vision...’ 
• External partners sharing evidence: ‘People in India are not really 
combining their expertise... instead of wasting time reinventing the wheel we 
really need [external partners] to come together...’  
• Empowering civil society with evidence:  
‘There has to be transparency in who uses the data... It’s a question of who 
owns the data, who owns the ideas...’ 
‘The democratic space is now open for [civil society] to speak on issues 
unlike in the past’  
 
 
5 Ongoing challenges getting evidence into action  
 
• Politics drives priority setting:  
‘...policies are not always made based on evidence... sometimes huge 
decisions are made within an hour...’  
‘If the data doesn’t favour them they become defensive’  
 
• Evidence ineffectively communicated: ‘90% of research that is done is 
sitting wherever – they’re published in Lancet then disappear, right? I think 
there’s this huge disconnect with people who do the research & people who 
advocate and people who make policy decisions’ 
 
• Lack of bandwidth within challenging programmatic environments: ‘I 
don’t think that the implementers have a lot of spare neurons to devote to 
working out how to adapt their own work plans on the basis of other 
experiences’   
• Fragmented, uncoordinated external programmes: ‘The more fragmented 
we are the less successful we will be... we have individual organisations’ 
mandates & competing products & services... how can we synergise & 
synchronise?’  
 
 
Summary  
1 Draw on multiple forms of evidence 
 
• Quantitative impact data  
• Estimated costs of scale-up 
• Process data 
• Demonstration 
 
2 Trustworthiness of evidence 
 
• Independence of evaluation 
• Bias/interests  
• Credibility of the messenger  
• Fostering trust 
 
3 Communicate evidence effectively 
  
• Audience 
• Format 
• Timing  
 
4 Supporting evidence-based decision 
making  
 
• Capacity building 
• Invoking champions  
• Sharing evidence   
• Empowering civil society  
 
5 Ongoing challenges  
 
• Politics & decision making  
• Ineffective communication 
• Bandwidth  
• Fragmentation 
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